Astragaloside IV attenuate MI-induced myocardial fibrosis and cardiac remodeling by inhibiting ROS/caspase-1/GSDMD signaling pathway

References

• Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics-2017 update: a report from the American Heart Association. Circulation. 2017 Mar 7;135(10):e146–e603. PubMed PMID: 28122885; PubMed Central PMCID: PMCPMC5408160.
   PubMed Web of Science ®Google Scholar
• Task Force on the management of STseamiotESoC, Steg PG, James SK, James SK, et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J. 2012 Oct;33(20):2569–2619. PubMed PMID: 22922416.
   PubMed Web of Science ®Google Scholar
• Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017Apr;42(4):245–254. PubMed PMID: 27932073.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhang Z, Ruan J, et al. Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores. Nature. 2016 Jul 7;535(7610):153–158. PubMed PMID: 27383986; PubMed Central PMCID: PMCPMC5539988.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu X, Shi H, et al. NLRP3 inflammasome, an immune‐inflammatory target in pathogenesis and treatment of cardiovascular diseases. Clin Transl Med. 2020;10(1):91–106.
   PubMed Web of Science ®Google Scholar
• Lei Q, Yi T, Chen C. NF-κB-gasdermin D (GSDMD) axis couples oxidative stress and NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome-mediated cardiomyocyte pyroptosis following myocardial infarction. Med Sci Monit. 2018;24:6044–6052.
   PubMed Web of Science ®Google Scholar
• Takahashi M. NLRP3 inflammasome as a novel player in myocardial infarction. Int Heart J. 2014;55(2):101–105. PubMed PMID: 24632952.
   PubMed Web of Science ®Google Scholar
• Audia JP, Yang XM, Crockett ES, et al. Caspase-1 inhibition by VX-765 administered at reperfusion in P2Y12 receptor antagonist-treated rats provides long-term reduction in myocardial infarct size and preservation of ventricular function. Basic Res Cardiol. 2018 Jul 10;113(5):32. PubMed PMID: 29992382; PubMed Central PMCID: PMCPMC6396295.
   PubMed Web of Science ®Google Scholar
• Chen A, Chen Z, Xia Y, et al. Liraglutide attenuates NLRP3 inflammasome-dependent pyroptosis via regulating SIRT1/NOX4/ROS pathway in H9c2 cells. Biochem Biophys Res Commun. 2018 May 5;499(2):267–272. PubMed PMID: 29571736.
   PubMed Web of Science ®Google Scholar
• Xu XL, Ji H, Gu SY, et al. Modification of alterations in cardiac function and sarcoplasmic reticulum by astragaloside IV in myocardial injury in vivo. Eur J Pharmacol. 2007 Jul 30;568(1–3):203–212. PubMed PMID: 17509559.
   PubMed Web of Science ®Google Scholar
• Wang SG, Xu Y, Chen JD, et al. Astragaloside IV stimulates angiogenesis and increases nitric oxide accumulation via JAK2/STAT3 and ERK1/2 pathway. Molecules. 2013 Oct 16;18(10):12809–12819. PubMed PMID: 24135938; PubMed Central PMCID: PMCPMC6270590.
   PubMed Web of Science ®Google Scholar
• Dong Z, Zhao P, Xu M, et al. Astragaloside IV alleviates heart failure via activating PPARalpha to switch glycolysis to fatty acid beta-oxidation. Sci Rep. 2017 Jun 2;7(1):2691. PubMed PMID: 28578382; PubMed Central PMCID: PMCPMC5457407.
   PubMedGoogle Scholar
• Zhao Z, Wang W, Wang F, et al. Effects of astragaloside IV on heart failure in rats. Chin Med. 2009 Apr 2;4(1):6. PubMed PMID: 19338675; PubMed Central PMCID: PMCPMC2674594.
   PubMedGoogle Scholar
• Wang Y, Xie Z, Jiang N, et al. Hispidulin attenuates cardiac hypertrophy by improving mitochondrial dysfunction. Front Cardiovasc Med. 2020;7:582890. PubMed PMID: 33324687; PubMed Central PMCID: PMCPMC7726192.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhao D, Feng J, et al. LuQi formula regulates NLRP3 inflammasome to relieve myocardial-infarction-induced cardiac remodeling in mice. Evid Based Complement Alternat Med. 2021;2021:1–14.
   Web of Science ®Google Scholar
• Hu L, Wang H, Huang L, et al. The protective roles of ROS-mediated mitophagy on (125)I seeds radiation induced cell death in HCT116 cells. Oxid Med Cell Longev. 2016;2016:9460462. PubMed PMID: 28119765; PubMed Central PMCID: PMCPMC5227180 people or organizations that could inappropriately influence this work.
   PubMed Web of Science ®Google Scholar
• Prabhu SD, Frangogiannis NG. The biological basis for cardiac repair after myocardial infarction: from inflammation to fibrosis. Circ Res. 2016 Jun 24;119(1):91–112. PubMed PMID: 27340270; PubMed Central PMCID: PMCPMC4922528.
   PubMed Web of Science ®Google Scholar
• Yan X, Anzai A, Katsumata Y, et al. Temporal dynamics of cardiac immune cell accumulation following acute myocardial infarction. J Mol Cell Cardiol. 2013 Sep;62:24–35. PubMed PMID: 23644221.
   PubMed Web of Science ®Google Scholar
• Ye X, Liu X, Wei W, et al. Volume-activated chloride channels contribute to lipopolysaccharide plus nigericin-induced pyroptosis in bone marrow-derived macrophages. Biochem Pharmacol. 2021 Nov;193:114791. PubMed PMID: 34582774.
   PubMed Web of Science ®Google Scholar
• Cheng S, Yu P, Yang L, et al. Astragaloside IV enhances cardioprotection of remote ischemic conditioning after acute myocardial infarction in rats. Am J Transl Res. 2016;8(11):4657–4669. PubMed PMID: 27904669; PubMed Central PMCID: PMCPMC5126311.
   PubMed Web of Science ®Google Scholar
• Zhao P, Wang Y, Zeng S, et al. Protective effect of astragaloside IV on lipopolysaccharide-induced cardiac dysfunction via downregulation of inflammatory signaling in mice. Immunopharmacol Immunotoxicol. 2015;37(5):428–433. PubMed PMID: 26376109.
   PubMed Web of Science ®Google Scholar
• Ong SB, Hernandez-Resendiz S, Crespo-Avilan GE, et al. Inflammation following acute myocardial infarction: multiple players, dynamic roles, and novel therapeutic opportunities. Pharmacol Ther. 2018 Jun;186:73–87. PubMed PMID: 29330085; PubMed Central PMCID: PMCPMC5981007.
   PubMed Web of Science ®Google Scholar
• Liu J, Wang H, Li J. Inflammation and Inflammatory cells in myocardial infarction and reperfusion injury: a double-edged sword. Clin Med Insights Cardiol. 2016;10:79–84. PubMed PMID: 27279755; PubMed Central PMCID: PMCPMC4892199.
   PubMed Web of Science ®Google Scholar
• Schaefer L. Complexity of danger: the diverse nature of damage-associated molecular patterns. J Biol Chem. 2014 Dec 19;289(51):35237–35245. PubMed PMID: 25391648; PubMed Central PMCID: PMCPMC4271212.
   PubMed Web of Science ®Google Scholar
• Gross O, Thomas CJ, Guarda G, et al. The inflammasome: an integrated view. Immunol Rev. 2011Sep;243(1):136–151. PubMed PMID: 21884173.
   PubMed Web of Science ®Google Scholar
• Toldo S, Mezzaroma E, O’Brien L, et al. Interleukin-18 mediates interleukin-1-induced cardiac dysfunction. Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1025–31. PubMed PMID: 24531812; PubMed Central PMCID: PMCPMC3962640.
   PubMed Web of Science ®Google Scholar
• Abbate A, Van Tassell BW, Biondi-Zoccai GG. Blocking interleukin-1 as a novel therapeutic strategy for secondary prevention of cardiovascular events. Biodrugs. 2012 Aug 1;26(4):217–233. PubMed PMID: 22571369.
   PubMed Web of Science ®Google Scholar
• Hansen PR. Role of neutrophils in myocardial ischemia and reperfusion. Circulation. 1995 Mar 15;91(6):1872–1885. PubMed PMID: 7882499.
   PubMed Web of Science ®Google Scholar
• Zouridakis EG, Garcia-Moll X, Kaski JC. Usefulness of the blood lymphocyte count in predicting recurrent instability and death in patients with unstable angina pectoris. Am J Cardiol. 2000;86(4):449–451.
   PubMed Web of Science ®Google Scholar
• Murphy SP, Kakkar R, McCarthy CP, et al. Inflammation in heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2020 Mar 24;75(11):1324–1340. PubMed PMID: 32192660.
   PubMed Web of Science ®Google Scholar
• Cai H, Liu Y, Men H, et al. Protective mechanism of humanin against oxidative stress in aging-related cardiovascular diseases. Front Endocrinol (Lausanne). 2021;12:683151. PubMed PMID: 34177809; PubMed Central PMCID: PMCPMC8222669.
   PubMed Web of Science ®Google Scholar
• Sun Y, Rawish E, Nording HM, et al. Inflammation in metabolic and cardiovascular disorders-role of oxidative stress. Life (Basel). 2021 Jul 9;11(7). DOI:10.3390/life11070672. PubMed PMID: 34357044; PubMed Central PMCID: PMCPMC8308054.
   Web of Science ®Google Scholar
• Tian X, He W, Yang R, et al. Dl-3-n-butylphthalide protects the heart against ischemic injury and H9c2 cardiomyoblasts against oxidative stress: involvement of mitochondrial function and biogenesis. J Biomed Sci. 2017 Jun 15;24(1):38. PubMed PMID: 28619102; PubMed Central PMCID: PMCPMC5471652.
   PubMedGoogle Scholar
• Lei Q, Yi T, Chen C. NF-kappaB-gasdermin D (GSDMD) axis couples oxidative stress and NACHT, LRR and PYD domains-containing protein 3 (NLRP3) inflammasome-mediated cardiomyocyte pyroptosis following myocardial infarction. Med Sci Monit. 2018 Aug 30;24:6044–6052. PubMed PMID: 30161099; PubMed Central PMCID: PMCPMC6128186.
   PubMed Web of Science ®Google Scholar
• Lamkanfi M, Dixit VM. Mechanisms and functions of inflammasomes. Cell. 2014 May 22;157(5):1013–1022. PubMed PMID: 24855941.
   PubMed Web of Science ®Google Scholar
• Qiu Z, He Y, Ming H, et al. Lipopolysaccharide (LPS) aggravates high glucose- and hypoxia/reoxygenation-Induced injury through activating ROS-Dependent NLRP3 inflammasome-mediated pyroptosis in H9C2 cardiomyocytes. J Diabetes Res. 2019;2019:1–12.
   Web of Science ®Google Scholar
• Mezzaroma E, Toldo S, Farkas D, et al. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19725–19730. PubMed PMID: 22106299; PubMed Central PMCID: PMCPMC3241791.
   PubMed Web of Science ®Google Scholar
• Ding J, Wang K, Liu W, et al. Pore-forming activity and structural autoinhibition of the gasdermin family. Nature. 2016 Jul 7;535(7610):111–116. PubMed PMID: 27281216.
   PubMed Web of Science ®Google Scholar
• Hornung V, Bauernfeind F, Halle A, et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008Aug;9(8):847–856. PubMed PMID: 18604214; PubMed Central PMCID: PMCPMC2834784.
   PubMed Web of Science ®Google Scholar
• Orlowski GM, Colbert JD, Sharma S, et al. Multiple cathepsins promote Pro-IL-1beta synthesis and NLRP3-mediated IL-1beta activation. J Immunol. 2015 Aug 15;195(4):1685–1697. PubMed PMID: 26195813; PubMed Central PMCID: PMCPMC4530060.
   PubMed Web of Science ®Google Scholar
• Bai Y, Sun X, Chu Q, et al. Caspase-1 regulate AngII-induced cardiomyocyte hypertrophy via upregulation of IL-1beta. Biosci Rep. 2018 Feb 12. DOI:10.1042/BSR20171438. PubMed PMID: 29440460; PubMed Central PMCID: PMCPMC5857903.
   Google Scholar
• Rathkey JK, Zhao J, Liu Z, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018 Aug 24;3(26). DOI:10.1126/sciimmunol.aat2738. PubMed PMID: 30143556; PubMed Central PMCID: PMCPMC6462819.
   PubMed Web of Science ®Google Scholar
• Andreadou I, Cabrera-Fuentes HA, Devaux Y, et al. Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities. Cardiovasc Res. 2019 Jun 1;115(7):1117–1130. PubMed PMID: 30825305; PubMed Central PMCID: PMCPMC6529904.
   PubMed Web of Science ®Google Scholar
• Xiao J, Wang C, Yao JC, et al. Gasdermin D mediates the pathogenesis of neonatal-onset multisystem inflammatory disease in mice. PLoS Biol. 2018Nov;16(11):e3000047. PubMed PMID: 30388107; PubMed Central PMCID: PMCPMC6235378 following competing interests: GM is a consultant for Aclaris Therapeutics, Inc., and holds stocks of this company. RC receives research support from Amgen, and holds stock of Amgen, Eli- Lilly, and Merck & Co.
   PubMed Web of Science ®Google Scholar